GRI Bio, Inc.

GRI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
424B3 Dec 15, 2023 424B3
CORRESP Dec 14, 2023
8-K Dec 5, 2023 8-K
CORRESP Dec 4, 2023
S-1/A Dec 4, 2023 S-1
8-K Nov 27, 2023 8-K
8-K Nov 24, 2023 8-K
UPLOAD Nov 21, 2023
8-K Nov 15, 2023 8-K
10-Q Nov 14, 2023 10-Q
8-K Nov 1, 2023 8-K
S-3 Oct 13, 2023 S-3
4 Sep 26, 2023 FORM 4
8-K Aug 25, 2023 8-K
8-K Aug 23, 2023 8-K
4 Aug 14, 2023 FORM 4
4 Aug 14, 2023 FORM 4
4 Aug 14, 2023 FORM 4
4 Aug 14, 2023 FORM 4
10-Q Aug 14, 2023 10-Q
8-K Aug 14, 2023 8-K
8-K Jul 7, 2023 8-K
8-K/A Jul 6, 2023 8-K/A
EFFECT Jun 7, 2023
424B3 Jun 7, 2023 424B3
← Newer Page 9 of 17 · 401 filings Older →